Advertisement

Topics

FDA expands indication for Eli Lilly's Cyramza to include patients with previously treated HCC http://bit.ly/2Vu2NY2  $LLY

18:11 EDT 10 May 2019 | FirstWord Pharma

FDA expands indication for Eli Lilly's Cyramza to include patients with previously treated HCC http://bit.ly/2Vu2NY2 

Original Article: FDA expands indication for Eli Lilly's Cyramza to include patients with previously treated HCC http://bit.ly/2Vu2NY2  $LLY

NEXT ARTICLE

More From BioPortfolio on "FDA expands indication for Eli Lilly's Cyramza to include patients with previously treated HCC http://bit.ly/2Vu2NY2  $LLY"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...